Overview
- The researchers published their results in Nature Neuroscience on August 4, 2026, describing a stem‑cell‑derived three‑dimensional spheroid that integrates neurons, astrocytes and microglia.
- When engineered to mimic Alzheimer’s, the spheroids developed amyloid deposits, increased phospho‑tau and neuroinflammation, and treatment with anti‑Aβ antibodies cleared plaques and shifted microglial disease signatures toward normal.
- The tissues form functional synaptic networks and include microglia that survive for more than six months with mature morphology, gene expression and active surveillance behavior.
- The protocol is highly reproducible and fast: human induced pluripotent stem cells self‑organize into pinhead‑sized spheroids in about a week using a defined differentiation cocktail and nutrient medium.
- The team is adapting the system for robotic automation to produce hundreds or thousands of standardized disease models for high‑throughput drug screening, with next steps including cross‑lab validation, broader pharmacological testing and engagement with translational and regulatory pathways.